Sign In
Buy CYCC
Cyclacel Pharmaceuticals Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be positive at 27.27. In total, the insiders bought 412.36M and sold 390.43M CYCC shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
27.27 |
| ● Buy | 412.36M shares |
| ● Sell | 390.43M shares |
|
88% Buy Activity
Negligible or No Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Feb 26, 2025 Sell |
Lazar David E. Interim CEO |
194 628 820 Value: $5.51M |
||
|
Feb 26, 2025 Buy |
Lazar David E. Interim CEO |
1 745 262 Value: $560.2K |
||
|
Feb 26, 2025 Buy |
Lazar David E. Interim CEO |
2 650 000 Value: $850.7K |
||
|
Feb 26, 2025 Buy |
Lazar David E. Interim CEO |
191 978 820 Value: $61.6M |
||
|
Feb 26, 2025 Buy |
Natan David Director |
700 000 Value: $231.0K |
||
|
Feb 06, 2025 Buy |
Lazar David E. Interim CEO |
2 100 000 Value: $691.7K |
||
|
Feb 06, 2025 Buy |
Lazar David E. Interim CEO |
2 100 000 Value: $691.7K |
||
|
Jan 05, 2025 Buy |
Ben-tzvi Avraham Director |
0 Value: $0 |
||
|
Jan 05, 2025 Buy |
Ben-tzvi Avraham Director |
0 Value: $0 |
||
|
Jan 02, 2025 Buy |
Natan David Director |
100 000 Value: $37.1K |
||
|
Jan 02, 2025 Buy |
Natan David Director |
0 Value: $0 |
||
|
Jan 02, 2025 Buy |
Lazar David E. Chief Executive Officer |
0 Value: $0 |
||
|
Jan 02, 2025 Buy |
Lazar David E. Chief Executive Officer |
2 650 000 Value: $982.9K |
||
|
Jan 02, 2025 Buy |
Lazar David E. Chief Executive Officer |
2 650 000 Value: $982.9K |
||
|
Jan 02, 2025 Buy |
Lazar David E. Chief Executive Officer |
0 Value: $0 |
||
|
Jan 02, 2025 Buy |
Natan David Director |
0 Value: $0 |
||
|
Jan 02, 2025 Buy |
Natan David Director |
100 000 Value: $37.1K |
||
|
Jan 29, 2024 Buy |
Schwartz Brian Interim Chief Medical Officer |
12 500 Value: $0 |
||
|
Jan 29, 2024 Buy |
Schwartz Brian Interim Chief Medical Officer |
12 500 Value: $28.5K |
||
|
Jan 29, 2024 Buy |
Schwartz Brian Interim Chief Medical Officer |
12 500 Value: $28.5K |
||
|
Jan 29, 2024 Buy |
Schwartz Brian Interim Chief Medical Officer |
12 500 Value: $0 |
||
|
Dec 21, 2023 Buy |
Rombotis Spiro George President And CEO |
6 070 Value: $19.4K |
||
|
Dec 21, 2023 Buy |
Rombotis Spiro George President And CEO |
6 070 Value: $20.1K |
||
|
Dec 21, 2023 Buy |
Mcbarron Paul See Remarks |
1 886 Value: $6K |
||
|
Dec 21, 2023 Buy |
Mcbarron Paul See Remarks |
1 886 Value: $6K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
